ZA201000987B - Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith - Google Patents

Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Info

Publication number: ZA201000987B
Authority: ZA; South Africa
Prior art keywords: benzothiazol; isoxazol; morpholin; imidazo; ethoxy
Prior art date: 2007-09-19

Application number

ZA2010/00987A

Inventor

Valeriya N Smolenskaya

Melanie J Roe

Stephen D Parent

Wei Lai

Shripad Bhagwat

Alan Schwartz

Original Assignee

Ambit Biosciences Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-19

Filing date

2010-02-10

Publication date

2011-04-28

2008-09-19 Priority claimed from PCT/US2008/010884 external-priority patent/WO2009038757A2/en

2010-02-10 Application filed by Ambit Biosciences Corp filed Critical Ambit Biosciences Corp

2011-04-28 Publication of ZA201000987B publication Critical patent/ZA201000987B/en

Links

239000000203 mixture Substances 0.000 title 1
CVWXJKQAOSCOAB-UHFFFAOYSA-N quizartinib Chemical compound O1C(C(C)(C)C)=CC(NC(=O)NC=2C=CC(=CC=2)C=2N=C3N(C4=CC=C(OCCN5CCOCC5)C=C4S3)C=2)=N1 CVWXJKQAOSCOAB-UHFFFAOYSA-N 0.000 title 1
239000007787 solid Substances 0.000 title 1

ZA2010/00987A 2007-09-19 2010-02-10 Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith ZA201000987B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US94463507P	2007-09-19	2007-09-19
PCT/US2008/010884 WO2009038757A2 (en)	2007-09-19	2008-09-19	Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Publications (1)

Publication Number	Publication Date
ZA201000987B true ZA201000987B (en)	2011-04-28

Family

ID=61026573

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA2010/00987A ZA201000987B (en)	2007-09-19	2010-02-10	Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith

Country Status (1)

Country	Link
ZA (1)	ZA201000987B (en)

2010
- 2010-02-10 ZA ZA2010/00987A patent/ZA201000987B/en unknown

Similar Documents

Publication	Publication Date	Title
IL203926A (en)	2016-02-29	Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof and uses thereof
EP1845086A4 (en)	2010-07-21	N-(2-substituted phenyl)-n-methoxycarbamates and their preparation as well as use
SG10201401826TA (en)	2014-10-30	Formulation comprising metformin and vildagli ptin
IL212308A0 (en)	2011-06-30	Solid forms of n-(4-(7-azabicyclo[2.2.1] heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and compositions comprising the same and uses thereof
EG25201A (en)	2011-11-14	4-cyclopropyl-1,2,3- thiadiazole compound, agrohorticultural plant disease controlling agent and method of using the same
PL2205244T3 (en)	2014-01-31	Methods of administering n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy-)imidazo-[2,1-b]-[1,3]-benzothiazol-2-yl]-phenyl}urea to treat proliferative disease
ZA200801630B (en)	2009-01-28	Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group,processes for their preparation and their use as pharmaceuticals
LTPA2017031I1 (en)	2017-11-10	8 - [{1- (3,5-Bis- (Trifluoromethyl) phenyl) ethoxy} -methyl] -8-phenyl-1,7-diaza-spiro [4.5] decan-2-one hydrochloride salt and the method of its preparation
NI201200072A (en)	2012-08-20	METHODS AND COMPOSITIONS TO TREAT CANCER
ZA200710342B (en)	2008-12-31	The preparation and use of compounds as aspartyl protease inhibitors
EP1954685A4 (en)	2009-11-11	Furoxan compounds, compositions and methods of use
AU2006321904A8 (en)	2008-07-17	1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
TW200613479A (en)	2006-05-01	Coating formulation having improved rheological properties
SI1902050T1 (en)	2010-01-29	Oxazolidinone derivatives and use thereof as antibiotics
EP1838165A4 (en)	2012-01-18	Methods for enhancing the palatability of compositions for consumption by animals
ZA200801896B (en)	2009-09-30	Slow-release composition, method for the preparation thereof, and use of the same
NZ627631A (en)	2016-10-28	Benzoheterocyclic compounds and use thereof
IL192328A (en)	2015-10-29	Yeast cell walls for use in the treatment and protection of plants against disease caused by pathogenic agents and compositions comprising said yeast cell walls
BRPI0810323A2 (en)	2014-10-14	"COMBINATION OF 5-CARBOXYLIC PYROLIDONE ACID, USE OF 5-CARBOXYLIC PYROLIDONE ACID, COMPOSITION AND USE"
EP1673384A4 (en)	2007-02-07	Nitrosated glutamic acid compounds, compositions and methods of use
EP1978099A4 (en)	2011-08-24	Antibacterial substance dm0507 and utilization of the same
GB0502787D0 (en)	2005-03-16	Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
EP1791423A4 (en)	2009-06-17	Compositions and methods for the management of hyperproliferative dermatological conditions
ZA201000987B (en)	2011-04-28	Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
ITMI20040162A1 (en)	2004-05-02	USE OF POLYAMINOMETHYLPHOSPHONATE AS DISPERSING AGENTS